Tag | Content |
---|
EnhancerAtlas ID | HS020-18584 |
Organism | Homo sapiens |
Tissue/cell | CD34+ |
Coordinate | chr17:28008290-28010980 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr17:28009684-28009702 | GGAAGGCAGGCAGGCAAG | + | 6.45 | EWSR1-FLI1 | MA0149.1 | chr17:28009692-28009710 | GGCAGGCAAGAAGGAAGG | + | 6.49 | EWSR1-FLI1 | MA0149.1 | chr17:28009672-28009690 | TGAAAGAAGGAAGGAAGG | + | 7.85 | EWSR1-FLI1 | MA0149.1 | chr17:28009696-28009714 | GGCAAGAAGGAAGGAAGG | + | 7.87 | EWSR1-FLI1 | MA0149.1 | chr17:28009676-28009694 | AGAAGGAAGGAAGGCAGG | + | 8.16 | EWSR1-FLI1 | MA0149.1 | chr17:28009680-28009698 | GGAAGGAAGGCAGGCAGG | + | 9.02 | NFAT5 | MA0606.1 | chr17:28009381-28009391 | AATGGAAAAT | - | 6.02 | NFATC1 | MA0624.1 | chr17:28009381-28009391 | AATGGAAAAT | - | 6.02 | NFATC3 | MA0625.1 | chr17:28009381-28009391 | AATGGAAAAT | - | 6.02 | SP3 | MA0746.2 | chr17:28010471-28010484 | CGCCCCGCCCACC | + | 6.14 |
|
| Number of super-enhancer constituents: 16 | ID | Coordinate | Tissue/cell |
SE_00091 | chr17:28008199-28012343 | Adipose_Nuclei | SE_04346 | chr17:28008697-28011336 | Brain_Anterior_Caudate | SE_05391 | chr17:28008606-28010878 | Brain_Cingulate_Gyrus | SE_07345 | chr17:28008386-28011023 | Brain_Hippocampus_Middle_150 | SE_08600 | chr17:28008692-28010340 | Brain_Inferior_Temporal_Lobe | SE_09243 | chr17:28007579-28011162 | CD14 | SE_10996 | chr17:28008103-28012533 | CD20 | SE_18775 | chr17:28008405-28010526 | CD4p_CD25-_Il17-_PMAstim_Th | SE_30972 | chr17:28008419-28011082 | Fetal_Thymus | SE_41508 | chr17:28009041-28011236 | Left_Ventricle | SE_43139 | chr17:28009234-28011103 | Lung | SE_48078 | chr17:28009018-28011294 | Psoas_Muscle | SE_51084 | chr17:28008609-28010633 | Skeletal_Muscle | SE_54418 | chr17:28008995-28011274 | Spleen | SE_58538 | chr17:28008486-28106930 | Ly1 | SE_62296 | chr17:28008388-28106801 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH17I029680 | chr17 | 28007170 | 28008351 | GH17I029681 | chr17 | 28008459 | 28011295 |
|
Enhancer Sequence | TGCAGTGAGC TGAGATTGCA CCACTGTACT CCAGCCTGGC CACAGAGTGA GACTGTCTCA 60 AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA GTAGCTTTTT CACGCAACAG GAAGGAAAGG 120 ACTGAATAAG GCACGCTTGG TATTTTTATC CAGGTTACCT CAGTCTCTCA AGATTTTTCT 180 CCATTTAAGT ATAACTACTT ATTTTAGTAA ATATTCAATT CATTCAATAA AAATTTATTT 240 AGTGCCTACT ATGTACCAGA CATTTCAAGG TGTTAGGGGT ACAAAAAGAA ATGGAAAAAA 300 AAAACCCCAA AAAACCATGA AGCTCTATTA TTTTATAACT TAAAATATGT TACACTTTAG 360 AAACCAAGAT TATGCTGCAT ATTTAAAAAA TTATTAAAAT ATAACATAAT ACTCAAAGAA 420 CTTGTAAATG GGCTAAATGA ATTGGCTGCA ACGTATTATT AAGAACTATT TGTACTTGTC 480 ATAATCTGGG TTCCACTTTG GCTTAATACT ATTTTGAAGC ATTAACATTT ACATTCTCAG 540 ATATGAAATG ATACAAATTC AAATTCCTTC AACAACAACT GAGACAGAAA TGATTTTAGA 600 TTACCTGAGC ATCTGAGACT TCTTACTGTC CAAGGAACTC ATTAAAGCAG AGGATGTATG 660 GGAATTTCAT AATAGCAAGT TTAGCAAACA GAATGAAAAC TAGTTTCTAG CTTTTCATGT 720 TTTAAGTTTG TCTTCTATAA ACTATAATTT CCTTTGGCTA GTGACACTGG TCAGATATGA 780 TTCAGACAGG GCCATTGGCA AAAGATAGAT GTAATTTACT GAGTATAAAC TACTGGATAC 840 CTATATTAAT ATGCATTCTT TCTGGTAAAG TTTAGGACAA AGTGAAAGAG AAATGATTAG 900 ACATGTGCTT GCTCATATTC TGGGTCAGGA GAATCTGCAG TTATTGTCTT CTGTCTCTAG 960 GGGAAGATTC AATTGAAGCT TCATGAGGTT CCTGTTCCTG TTTTATAGGG TTTTCAAGGG 1020 AGGGGGTCAG GGAGAACTGA ACAAAGGAAA TATGAGCTAG AACAGTGCTG TCCAACTGAA 1080 CTTTCTGCAA GAATGGAAAA TGTTCTATAC ATGTACTGTC TAATACGATA GCCACTAGCA 1140 CATACGGTTA CTGAATACTT GAAATGTGAC TAGTTAGAAC TGAGGAATTG AAATTTCATT 1200 TAATTTTAAT CTATTTAAAA AGACACGTGC ATGCTGTATG CAGTGGCTCA TGCCTATAAT 1260 CCCAGCACTC AGGAAGGCAG AGGCAGGAGC TCAGGAGTTG AGACCAGCCT GGGCAACACA 1320 GAGAGACTGT GTTCTTCACA AAAAGGAAAA AAGAAAAGAA GAGAAGAGAA AAGGAAGGAA 1380 GATGAAAGAA GGAAGGAAGG CAGGCAGGCA AGAAGGAAGG AAGGGGCACA TATGGTTAGT 1440 GGCTACTATA CTGGACAACA CAGATCTAGA AAGATTAAAA ACCTAAATTA GAGGTCCTAA 1500 AATCCTAATG AATGTAAACA AGGTAGGTGC TGTTATAGGA AAATGCTTAC TGAAAGCTCT 1560 GTTGCTTAAT CAGAAGTTAA AACCATGCAG GAGAAATCTT CCTAAATCTG GTTTACAAGC 1620 CTGTGTAAAT TCAGAGCCTA CAATTAAATG CTGTTAAGTG GTATACAAGC TAATAACTTT 1680 GGCTTTGGGA ATTCCTGTGA ACCCCCAAGT CATTTTCAGG TTGACTTCTA TATAGGAATA 1740 AGGTAAACAT TGGTTTGGGA AACTTTCTAG TGACAAAGTG ATTTTTTCCC CTCAACATCA 1800 GGAAAATTAG AATCATTCCC AGGCTCCTCC TCTCTTTGTG GCTAAATTTC CCTAGGCCTG 1860 GGTCACACCC CTAGCTACCC CATAGTTCCA TTCTAATCCT GAACCAGGAA GTCAATGCTT 1920 TGAGACATCT GGCAGGATTT CCTGAGGCTA ATTATCCACA GCGTAAAGAT CTGCTTAGCA 1980 GCCACATTCC AAAGTCTTCC GAAGGTTTCT CCAGAAAAAG TGGGAAAAAT AAAAAAGGAA 2040 AGCAACAAAC CTTAAGGACA CACGAAAAGG CCAGGTGTTG TGTGTCATCT TTCATCATAG 2100 AATGTAAAGT ACAGCTAAAG CCAAAGGTAC ATAAAAAGTT CTGCTTTGAG TTTAAGGAGC 2160 CATCCCGTAC CACCCCATCC CCGCCCCGCC CACCATCCTT TTTAACTCAA TAGAAGGAAA 2220 AAGGAGGCAT AGCATTTGGT AAAAGCAAGG TTTAAACAAA ACAGACTGTA GTTTAAGTGG 2280 GATCTCTTTG TATCTGGGAC TACTGGTATA CTACCACAAA GGGTAGGTGC CCTAGAATCA 2340 CCAAAGTGAA TCATTACTGA CTACAATAGA GTAGGCCAGG TGCAAGGCTC ATGCCTGTAA 2400 TCCCAGCACT TTGGGAAGCC GAAGTGGGAG GATTGCTTAA GCCCAAGAAT TCAAGACCAG 2460 CCTGGCCAAC ATAAGGAAAT CTTCTCTCCA GAAAAATAAG GAAAAAAAAA AAAAAAAGAC 2520 CAAATAGCTG GGTATGGTGG TGCATGCCTG TACTTCTAGC TACTTAGGAG GCTGAGGTGG 2580 AAGGATTCCT AGAGCCCAGG AGGAATTTGA GGCCGTAGTG AGCTGTGACT GCATCACGGC 2640 ACTTCAGCCT GGGCAGCAGA GCGAGACGCT GTCTCAAAAA GAGAAATAAA 2690
|